Login

Graham Curren, Founder & CEO of Sondrel, expresses confidence in the company's IPO prospects despite market conditions. 00:10:00

Share On Facebook Share On Twitter

Graham Curren, Founder & CEO of Sondrel

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Raising Money Isn't A Measurement Of Success|Robb Doub,General Partner,New Markets Venture Partners
00:10:00
WISeKey's Founder & CEO Carlos Moreira explains how the company utilizes satellites to safeguard data.|Carlos Creus Moreira is the Founder Chairman CEO of WISeKey.
00:10:00
He is the CFO of 4iG among the best | Gellért Jászai, CEO, 4iG Nyrt4IG:BUD
00:10:00
Ho Kuen Loon, Group CEO, and Ng Chong Jin, Group General Counsel of Fullerton Health, discuss their award-winning project and outline future plans for the company.
00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited
00:10:00
Treatment of cancer in dogs and neurodegenerative diseases in humans.|Dr Michael Thurn,Chief Executive Officer,PharmAust Ltd
00:10:00
Biblical Wealth Principles: Nurturing Financial Growth | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
From Law to Private Equity: Jeffrey Leeds' Journey to Success | Jeffrey Leeds, President & Co-founder, Leeds Equity Partners.
00:10:00
Corvus Gold CEO Discusses Resource Expansion, Strong Financial Position, and Strategic Developments at the One-to-One Conference in New York
00:10:00
Forward-Thinking Leadership: Wol Kolade on Vision, Ethics, and Business Culture | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Conversations with Clinton and Bush: Leadership Reflections
00:10:00
A mission-driven investment firm seeking to create outstanding|Pete Oberle,Managing Partner,Trailhead Capital

© 2026 Nehu